Introduction The respiratory syncytial virus (RSV) is a leading cause of respiratory infections in infants, young children, and the elderly, making the development of an effective RSV vaccine crucial for public health. As infections spike during the winter months, the need for preventive measures has become increasingly urgent. Recent advances in vaccine research have shown